Ibuprofen may be quietly changing cancer risk

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive. Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies. The exact mechanisms by which ibuprofen exerts its anti-cancer effects are not yet fully understood. As with any medication, its use should be carefully monitored and guided by a healthcare professional. The relationship between ibuprofen and cancer risk is still being researched and more studies are needed to confirm these findings. Some experts have noted that ibuprofen may have beneficial effects on certain types of cancer, but more research is required to fully understand its potential benefits and risks. Further investigation is needed to determine whether ibuprofen can be used as a tool to reduce cancer risk or if it has any impact on cancer progression. While ibuprofen may have some anti-cancer properties, it should not be relied upon as the sole means of cancer prevention or treatment.